Patrick  Spine net worth and biography

Patrick Spine Biography and Net Worth

SVP of Accuray
Senior Vice President and Chief Administrative Officer

Patrick Spine is the Senior Vice President and Chief Administrative Officer. In this role, he will be responsible for the global human resources functions, information technology, and facilities, with a focus on transformation to further enhance the overall culture for high performance and scalable growth.

Prior to joining Accuray, Patrick held multiple leadership positions and was previously with PRA Health Sciences as Vice President of Human Resources. During his six years with PRA, Spine was a key executive coach and led transformational projects to support the operational growth of the company from 4,000 employees to over 15,000, and a successful initial public offering. Other leadership positions include Director of Human Resources at Hospira, and multiple human resources roles with EATON. Over the course of his career, Spine has been instrumental in driving cultural changes for further operational success while implementing programs for sustainable growth. Spine brings a broad breadth of expertise in overall human resources management spanning diverse industries and small to large scale global operations.

Spine earned his Masters of Science degree in Human Resources from LaRoche College and a Bachelor of Science degree in Business Administration from Robert Morris University.

What is Patrick Spine's net worth?

The estimated net worth of Patrick Spine is at least $542,125.48 as of December 1st, 2023. Mr. Spine owns 219,484 shares of Accuray stock worth more than $542,125 as of March 29th. This net worth estimate does not reflect any other assets that Mr. Spine may own. Learn More about Patrick Spine's net worth.

How do I contact Patrick Spine?

The corporate mailing address for Mr. Spine and other Accuray executives is 1310 CHESAPEAKE TERRACE, SUNNYVALE CA, 94089. Accuray can also be reached via phone at (408) 716-4600 and via email at [email protected]. Learn More on Patrick Spine's contact information.

Has Patrick Spine been buying or selling shares of Accuray?

Patrick Spine has not been actively trading shares of Accuray in the last ninety days. Most recently, Patrick Spine sold 14,832 shares of the business's stock in a transaction on Friday, December 1st. The shares were sold at an average price of $2.47, for a transaction totalling $36,635.04. Following the completion of the sale, the senior vice president now directly owns 219,484 shares of the company's stock, valued at $542,125.48. Learn More on Patrick Spine's trading history.

Who are Accuray's active insiders?

Accuray's insider roster includes Jesse Chew (SVP), Brandon Green (CFO), Michael Hoge (VP), Joshua Levine (CEO), Byron Scott (Director), Patrick Spine (SVP), Joseph Whitters (Director), and Suzanne Winter (President). Learn More on Accuray's active insiders.

Are insiders buying or selling shares of Accuray?

In the last year, insiders at the medical equipment provider sold shares 15 times. They sold a total of 259,366 shares worth more than $711,680.25. The most recent insider tranaction occured on January, 3rd when CFO Ali Pervaiz sold 2,116 shares worth more than $5,797.84. Insiders at Accuray own 3.8% of the company. Learn More about insider trades at Accuray.

Information on this page was last updated on 1/3/2024.

Patrick Spine Insider Trading History at Accuray

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2023Sell14,832$2.47$36,635.04219,484View SEC Filing Icon  
12/1/2022Sell5,176$2.10$10,869.60208,561View SEC Filing Icon  
5/4/2022Sell1,559$2.65$4,131.35225,094View SEC Filing Icon  
11/2/2021Sell5,494$5.23$28,733.62View SEC Filing Icon  
5/2/2019Sell1,921$4.04$7,760.8429,329View SEC Filing Icon  
See Full Table

Patrick Spine Buying and Selling Activity at Accuray

This chart shows Patrick Spine's buying and selling at Accuray by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Accuray Company Overview

Accuray logo
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Read More

Today's Range

Now: $2.47
Low: $2.43
High: $2.51

50 Day Range

MA: $2.65
Low: $2.37
High: $2.94

2 Week Range

Now: $2.47
Low: $2.36
High: $4.30

Volume

423,690 shs

Average Volume

483,438 shs

Market Capitalization

$244.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.44